Trial Details
COMPLETEDBasic Information
| Clinical ID | c2101 |
|---|---|
| Identifier | NCT03977155 |
| Trial Title | Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Diarrhea-predominant Irritable Bowel Syndrome |
| Interventions | DRUG: BOS-589|DRUG: Placebo |
Participant Information
| Sponsor | Boston Pharmaceuticals |
|---|---|
| City | Anniston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-06-04 |
|---|---|
| Primary Completion Date | 2020-05-06 |
| Completion Date | 2020-05-06 |